What You Should Know:
- EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA).
- This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More
Digital Biomarkers
GrayMatters Health Raises $10M for Biomarker-Based PTSD Therapeutics
What You Should Know:
- GrayMatters Health (GMH), a company set to change the standards of mental health care with biomarker-based therapeutics, beginning with PTSD raises $10 million in Series A funding round led by Otsuka Medical Devices Co., Ltd., bringing total funding to $13.5 million. Additional investors in the Series A round included Joy Ventures, J-Ventures, and J-Impact. Existing GMH investors, Marius Nacht and Joyance Ventures, also
Read More
Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery
What You Should Know:
- Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery.
- As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More
Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection
What You Should Know:
- Mayo Clinic announced a collaboration with Vocalis
Health to to research and develop new voice-based tools for screening, detecting
and monitoring patient health, beginning with a study to identify vocal
biomarkers to detect pulmonary hypertension (PH).
- The clinical validation study will utilize Vocalis
Health’s proprietary software, which can operate on any connected voice
platform (mobile, computer, tablet, etc.) to analyze patients’ health based on
voice
Read More
Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors
What You Should Know:
- Clinical trials technology company Medidata has
acquired the digital biomarker business of MC10.
- MC10’s offerings will bring novel clinical analytics
and biosensor capabilities to Medidata’s existing technology solutions,
enhancing Medidata’s capabilities to integrate data from wearable sensors –
including clinical grade metrics – in clinical trials.
- With this acquisition, Medidata’s integrated offering
will help provide life sciences companies and device
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know:
- physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic.
- Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation.
The National Cancer
Institute
Read More
Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch
What You Should Know:
- Anthem, Inc. announced a new study that examines how
the use of everyday devices, like Apple Watch and iPhone, may help individuals
with asthma, led by the University of California, Irvine.
- Launching in the fall, the two-year, randomized controlled
study will enroll participants from Anthem-affiliated health plans who have
been clinically diagnosed with asthma.
-Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple Watch
Read More
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
What You Should Know:
- Sonde Health acquires NeuroLex Laboratories, Inc. to forms
one of the world’s preeminent biobanks focused on vocal biomarkers.
- NeuroLex’s core product, SurveyLex, makes it easy to
create and distribute voice surveys in less than a minute as URL links through
web browsers.
Sonde Health, a
Boston-based digital vocal biomarker technology platform announced it has acquired
NeuroLex Laboratories, Inc., a leading
voice-enabled survey and data acquisition platform.
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Backed by Optum Ventures, Kaia Health Raises $8M for AI-Driven Digital Therapeutics for Back Pain & COPD
- Digital therapeutics startup Kaia Health raises $8M in funding led by Optum Ventures to support the accelerated execution of clinical trials required to demonstrate efficacy to the FDA.- Kaia Health utilizes multimodal therapy, which combines physical, psychological and educational elements to relieve back pain at home, without medication.- Optum’s investment in Kaia Health will consider use of Kaia Health’s digital therapeutic offerings for back pain and COPD with Optum and UnitedHealth
Read More
